Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Atropine recalled?

Yes — there is an active recall. 13 ongoing FDA recalls mention Atropine (125 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Atropine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Atropine recalls on record

none so far in 2026; 125 on record, newest first
Class II · Moderate risk

Formula F2

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0002-10 D-0821-2022
Class II · Moderate risk

Qm-4

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0020-10 D-0812-2022
Class II · Moderate risk

Qm-3

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0019-10 D-0811-2022
Class II · Moderate risk

At-1

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0039-10 D-0802-2022
Class II · Moderate risk

At-6

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0040-10 D-0801-2022
Class II · Moderate risk

Formula F9

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy D-0800-2022
Class III · Low risk

Formula F9

Sub Potent

Terminated Wrong potency / content Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0004-10 D-0720-2022